Examining Engagement Patterns: An Observational Exploration About Tardive Dyskinesia Clinical Trials
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Tardive Dyskinesia
- Sponsor
- Power Life Sciences Inc.
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Rate of patients who decide to enroll in a tardive dyskinesia clinical research.
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials.
These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of tardive dyskinesia
- •Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- •No prior treatment for tardive dyskinesia
Exclusion Criteria
- •Enrolled in another research study
- •Inability to provide written informed consent
- •Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Outcomes
Primary Outcomes
Rate of patients who decide to enroll in a tardive dyskinesia clinical research.
Time Frame: 3 months
Number of tardive dyskinesia study participants who remain in clinical study until completion.
Time Frame: 12 months